The US Oncology Network | Strategic Alliance Partners

Precision medicine transforms cancer care, enhancing patient outcomes through targeted therapies, yet faces challenges in community access and biomarker testing.

Tennessee Cancer Specialists, the third largest oncology practice in the state, strengthens its ability to deliver cutting-edge advanced care by joining The Network.

Over 80% of non-small cell lung cancer detected at stage 4.

Key highlights include a plenary session on cervical cancer among women in developing nations and an oral abstract exploring molecular testing and targeted therapy for metastatic non-small cell lung cancer, among other topics.

By joining The Network, these physicians contribute to the expansion of colorectal services in Texas.

McKesson Specialty Health and the US Oncology Network have expanded their agreement with the National Comprehensive Cancer Network adding five additional disease states to Value Pathways powered by NCCN.

McKesson Specialty Health and The US Oncology Network today announced that Marcus Neubauer, MD, has accepted the position of medical director, Oncology Services for McKesson Specialty Health, to continue his work on pathways development.